CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Commences COVID-19 Drug Delivery Program
Mar 19, 2020
Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, this morning announced the initiation of a program, in collaboration with leading laboratories in Canada and the USA, to analyze the benefits of Lexaria’s DehydraTECH(TM) drug delivery platform for improving delivery and effectiveness of certain antiretroviral drugs in the fight against coronavirus disease COVID-19. Researchers around the world are currently examining several antiretroviral drugs, many of which are fat soluble, as possible candidates to combat COVID-19. When administered in oral form, fat soluble drugs are known to present considerable bioavailability challenges in effectively reaching the human bloodstream. Lexaria is an established leader in oral delivery of fat-soluble drugs. Lexaria plans to conduct a pilot human pharmacokinetic exploratory study in healthy volunteers of three antiretroviral drugs that have previously been studied against other coronavirus strains, assessing DehydraTECH formulations against controls without the technology. The company intends to conduct the study at a leading Canadian University where a study design and plan has already been submitted for ethics board approval. The company has held discussions with some laboratories that could potentially expand the number of prospective drugs using DehydraTECH under evaluation for coronavirus applications. Following positive conclusions from its planned research activities, Lexaria will aggressively engage with prospective strategic partners to enhance drug development where applicable.
To view the full press release, visit http://cnw.fm/xYe8u
About Lexaria
Lexaria Bioscience Corp. is a global innovator in drug delivery technology. Its patented DehydraTECH(TM) drug delivery technology changes the way active pharmaceutical ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bio-absorption; reduces time of onset; and masks unwanted tastes for orally administered bioactive molecules including nicotine, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and other molecules. Lexaria has licensed DehydraTECH to multiple companies for use in various oral application formats, including to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.
NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXX
About CanadianCannabisWire
CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CanadianCannabisWire.com
Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask our Editor
CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
[email protected]
More News
Nine CEO to oversee sprawling TV division after top executive’s exit
Amanda Laing joined the company in 2025 and oversaw Channel Nine, 9Now, and Stan but the company announced on Thursday that she is leaving.
Chinese carmaker’s new EV battery will charge in under five minutes
Geely has just upped the ante in its “flash charging” battle with rival BYD, unveiling a battery it says is the fastest in the industry.
The RBA will hike rates again but inflation is testing the bank’s most valuable asset
Our independent Reserve Bank is in a protracted battle against high inflation. But the RBA faces another reputational threat: credibility.
The world economy is becoming wary of America
Almost two years into Donald Trump’s second term, the global economy is looking for ways to distance itself from the United States.
I want to control my car without crashing it. Here’s where design is going wrong
Enshittification is spreading. Now everyday products are getting worse too. The biggest backward step is the high-tech feature that hides behind a pane of glass.
Fuel price fears for Australia as global buffers dry up
The world is burning through oil stockpiles at record speed, threatening more price pain at Australian petrol stations.
Financial Review editor-in-chief James Chessell quits to join media start-up
The paper’s editor Cosima Marriner has been appointed as editor-in-chief, becoming the first woman to hold the role.
The $16b Aussie tech firm in a slanging match over its China links
The $16 billion Australian payments unicorn remains very sensitive to criticism of its operations in China.
ASX finishes flat as miners rise, oil stocks struggle; IDP plummets
The Australian sharemarket was treading water on Wednesday, with gains by mining stocks offset by weaker energy stocks as oil dropped below the $US100-a-barrel mark.
I gave my life over to Meta’s AI agent and was blown away
Muse, Meta’s AI agent, helped handle my dental insurance, booked dinner reservations and created a podcast for me. It also required my most personal data, and trust.
Warren Buffett just took a big risk with the $1.5 trillion giant he built
At face value, 71-year-old farmer Howard Buffett has no obvious qualifications to be appointed chairman of a prestigious company, other than that he is the founder’s son. He couldn’t have a more daunting act to follow.
Critica product samples put WA Jupiter rare earths in offtake orbit
Critica Ltd has produced a high-purity 98.2 per cent total rare earth oxide sample and a high-grade iron by-product from its Jupiter project in WA, ahead of product offtake discussions.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.